Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 293 | 475 | 456 | 324 | 39 |
| Gross Profit | 293 | 475 | 456 | 324 | 39 |
| Operating Expenses | 17,109 | 14,741 | 16,077 | 16,114 | 15,174 |
| Operating Income | -16,816 | -14,266 | -15,621 | -15,790 | -15,135 |
| Interest Expense | 377 | 374 | 355 | 20 | 7 |
| Other Income | 44 | 26 | 33 | 61 | 553 |
| Pre-tax Income | -17,149 | -14,614 | -15,943 | -15,749 | -14,589 |
| Net Income Continuous | -17,149 | -14,614 | -15,943 | -12,237 | -14,589 |
| Net Income | $-17,149 | $-14,614 | $-15,943 | $-12,237 | $-14,589 |
| EPS Basic Total Ops | -0.22 | -0.22 | -0.25 | -0.21 | -0.29 |
| EPS Basic Continuous Ops | -0.22 | -0.22 | -0.25 | -0.21 | -0.29 |
| EPS Diluted Total Ops | -0.22 | -0.22 | -0.25 | -0.21 | -0.29 |
| EPS Diluted Continuous Ops | -0.22 | -0.22 | -0.25 | -0.21 | -0.29 |
| EBITDA(a) | $-16,441 | $-13,870 | $-15,209 | $-15,389 | $-14,706 |